|
|
|
|
|
|
by missedthecue
295 days ago
|
|
|
You have to get pretty lucky to invent something and get it though all trials and approval, but then you only get to earn money on it for a short period before it goes generic. There is literally no way to build a durable competitive moat in biotech. You just have to keep getting lucky. Eli Lilly has had a streak of luck lately, Pfizer and Biogen have been swinging and missing a lot. |
|
|